List of Excipients in API tolvaptan
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing tolvaptan
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Otsuka America Pharmaceutical Inc | SAMSCA | tolvaptan | 59148-020 | CELLULOSE, MICROCRYSTALLINE | |
Otsuka America Pharmaceutical Inc | SAMSCA | tolvaptan | 59148-020 | FD&C BLUE NO. 2--ALUMINUM LAKE | |
Otsuka America Pharmaceutical Inc | SAMSCA | tolvaptan | 59148-020 | HYDROXYPROPYL CELLULOSE | |
Otsuka America Pharmaceutical Inc | SAMSCA | tolvaptan | 59148-020 | LACTOSE MONOHYDRATE | |
Otsuka America Pharmaceutical Inc | SAMSCA | tolvaptan | 59148-020 | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | |
Otsuka America Pharmaceutical Inc | SAMSCA | tolvaptan | 59148-020 | MAGNESIUM STEARATE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing tolvaptan
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 | CROSCARMELLOSE SODIUM |
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 | FD&C BLUE NO. 2 |
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 | LACTOSE MONOHYDRATE |
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 | MAGNESIUM STEARATE |
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 | METHYL ALCOHOL |
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 | METHYLENE CHLORIDE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for tolvaptan
Excipient focus: ANHYDROUS LACTOSE
tolvaptan drug variants containing ANHYDROUS LACTOSE
Company | Ingredient | NDC |
---|---|---|
Apotex Corp | tolvaptan | 60505-4317 |
Apotex Corp | tolvaptan | 60505-4318 |
>Company | >Ingredient | >NDC |
tolvaptan drug variants not containing ANHYDROUS LACTOSE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 |
Par Pharmaceutical Inc | tolvaptan | 49884-768 |
Otsuka America Pharmaceutical Inc | tolvaptan | 59148-020 |
Apotex Corp | tolvaptan | 60505-4704 |
Ascend Laboratories LLC | tolvaptan | 67877-636 |
Novadoz Pharmaceuticals LLC | tolvaptan | 72205-130 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
tolvaptan drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | tolvaptan | 49884-768 |
Otsuka America Pharmaceutical Inc | tolvaptan | 59148-020 |
Apotex Corp | tolvaptan | 60505-4704 |
Ascend Laboratories LLC | tolvaptan | 67877-636 |
>Company | >Ingredient | >NDC |
tolvaptan drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 |
Apotex Corp | tolvaptan | 60505-4317 |
Apotex Corp | tolvaptan | 60505-4318 |
Novadoz Pharmaceuticals LLC | tolvaptan | 72205-130 |
>Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
tolvaptan drug variants containing COPOVIDONE K25-31
Company | Ingredient | NDC |
---|---|---|
Apotex Corp | tolvaptan | 60505-4317 |
Apotex Corp | tolvaptan | 60505-4318 |
>Company | >Ingredient | >NDC |
tolvaptan drug variants not containing COPOVIDONE K25-31
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 |
Par Pharmaceutical Inc | tolvaptan | 49884-768 |
Otsuka America Pharmaceutical Inc | tolvaptan | 59148-020 |
Apotex Corp | tolvaptan | 60505-4704 |
Ascend Laboratories LLC | tolvaptan | 67877-636 |
Novadoz Pharmaceuticals LLC | tolvaptan | 72205-130 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
tolvaptan drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 |
Apotex Corp | tolvaptan | 60505-4317 |
Apotex Corp | tolvaptan | 60505-4318 |
Ascend Laboratories LLC | tolvaptan | 67877-636 |
Novadoz Pharmaceuticals LLC | tolvaptan | 72205-130 |
>Company | >Ingredient | >NDC |
tolvaptan drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | tolvaptan | 49884-768 |
Otsuka America Pharmaceutical Inc | tolvaptan | 59148-020 |
Apotex Corp | tolvaptan | 60505-4704 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
tolvaptan drug variants containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 |
Par Pharmaceutical Inc | tolvaptan | 49884-768 |
Apotex Corp | tolvaptan | 60505-4317 |
Apotex Corp | tolvaptan | 60505-4318 |
Ascend Laboratories LLC | tolvaptan | 67877-636 |
>Company | >Ingredient | >NDC |
tolvaptan drug variants not containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
Otsuka America Pharmaceutical Inc | tolvaptan | 59148-020 |
Apotex Corp | tolvaptan | 60505-4704 |
Novadoz Pharmaceuticals LLC | tolvaptan | 72205-130 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2 ALUMINUM LAKE
tolvaptan drug variants containing FD&C BLUE NO. 2 ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
Novadoz Pharmaceuticals LLC | tolvaptan | 72205-130 |
>Company | >Ingredient | >NDC |
tolvaptan drug variants not containing FD&C BLUE NO. 2 ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 |
Par Pharmaceutical Inc | tolvaptan | 49884-768 |
Otsuka America Pharmaceutical Inc | tolvaptan | 59148-020 |
Apotex Corp | tolvaptan | 60505-4317 |
Apotex Corp | tolvaptan | 60505-4318 |
Apotex Corp | tolvaptan | 60505-4704 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
tolvaptan drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
Otsuka America Pharmaceutical Inc | tolvaptan | 59148-020 |
Apotex Corp | tolvaptan | 60505-4704 |
>Company | >Ingredient | >NDC |
tolvaptan drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 |
Par Pharmaceutical Inc | tolvaptan | 49884-768 |
Apotex Corp | tolvaptan | 60505-4317 |
Apotex Corp | tolvaptan | 60505-4318 |
Ascend Laboratories LLC | tolvaptan | 67877-636 |
Novadoz Pharmaceuticals LLC | tolvaptan | 72205-130 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
tolvaptan drug variants containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | tolvaptan | 49884-768 |
Otsuka America Pharmaceutical Inc | tolvaptan | 59148-020 |
Apotex Corp | tolvaptan | 60505-4704 |
Novadoz Pharmaceuticals LLC | tolvaptan | 72205-130 |
>Company | >Ingredient | >NDC |
tolvaptan drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 |
Apotex Corp | tolvaptan | 60505-4317 |
Apotex Corp | tolvaptan | 60505-4318 |
Ascend Laboratories LLC | tolvaptan | 67877-636 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
tolvaptan drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | tolvaptan | 49884-768 |
>Company | >Ingredient | >NDC |
tolvaptan drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 |
Otsuka America Pharmaceutical Inc | tolvaptan | 59148-020 |
Apotex Corp | tolvaptan | 60505-4317 |
Apotex Corp | tolvaptan | 60505-4318 |
Apotex Corp | tolvaptan | 60505-4704 |
Ascend Laboratories LLC | tolvaptan | 67877-636 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
tolvaptan drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Ascend Laboratories LLC | tolvaptan | 67877-636 |
>Company | >Ingredient | >NDC |
tolvaptan drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 |
Par Pharmaceutical Inc | tolvaptan | 49884-768 |
Otsuka America Pharmaceutical Inc | tolvaptan | 59148-020 |
Apotex Corp | tolvaptan | 60505-4317 |
Apotex Corp | tolvaptan | 60505-4318 |
Apotex Corp | tolvaptan | 60505-4704 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
tolvaptan drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 |
Par Pharmaceutical Inc | tolvaptan | 49884-768 |
Otsuka America Pharmaceutical Inc | tolvaptan | 59148-020 |
Apotex Corp | tolvaptan | 60505-4704 |
Ascend Laboratories LLC | tolvaptan | 67877-636 |
Novadoz Pharmaceuticals LLC | tolvaptan | 72205-130 |
>Company | >Ingredient | >NDC |
tolvaptan drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Apotex Corp | tolvaptan | 60505-4317 |
Apotex Corp | tolvaptan | 60505-4318 |
>Company | >Ingredient | >NDC |
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
tolvaptan drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Otsuka America Pharmaceutical Inc | tolvaptan | 59148-020 |
Apotex Corp | tolvaptan | 60505-4704 |
>Company | >Ingredient | >NDC |
tolvaptan drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 |
Par Pharmaceutical Inc | tolvaptan | 49884-768 |
Apotex Corp | tolvaptan | 60505-4317 |
Apotex Corp | tolvaptan | 60505-4318 |
Ascend Laboratories LLC | tolvaptan | 67877-636 |
Novadoz Pharmaceuticals LLC | tolvaptan | 72205-130 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
tolvaptan drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 |
Par Pharmaceutical Inc | tolvaptan | 49884-768 |
Otsuka America Pharmaceutical Inc | tolvaptan | 59148-020 |
Apotex Corp | tolvaptan | 60505-4317 |
Apotex Corp | tolvaptan | 60505-4318 |
Apotex Corp | tolvaptan | 60505-4704 |
>Company | >Ingredient | >NDC |
tolvaptan drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: METHYL ALCOHOL
tolvaptan drug variants containing METHYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 |
>Company | >Ingredient | >NDC |
tolvaptan drug variants not containing METHYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | tolvaptan | 49884-768 |
Otsuka America Pharmaceutical Inc | tolvaptan | 59148-020 |
Apotex Corp | tolvaptan | 60505-4317 |
Apotex Corp | tolvaptan | 60505-4318 |
Apotex Corp | tolvaptan | 60505-4704 |
Ascend Laboratories LLC | tolvaptan | 67877-636 |
>Company | >Ingredient | >NDC |
Excipient focus: METHYLENE CHLORIDE
tolvaptan drug variants containing METHYLENE CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 |
>Company | >Ingredient | >NDC |
tolvaptan drug variants not containing METHYLENE CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | tolvaptan | 49884-768 |
Otsuka America Pharmaceutical Inc | tolvaptan | 59148-020 |
Apotex Corp | tolvaptan | 60505-4317 |
Apotex Corp | tolvaptan | 60505-4318 |
Apotex Corp | tolvaptan | 60505-4704 |
Ascend Laboratories LLC | tolvaptan | 67877-636 |
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
tolvaptan drug variants containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 |
Novadoz Pharmaceuticals LLC | tolvaptan | 72205-130 |
>Company | >Ingredient | >NDC |
tolvaptan drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | tolvaptan | 49884-768 |
Otsuka America Pharmaceutical Inc | tolvaptan | 59148-020 |
Apotex Corp | tolvaptan | 60505-4317 |
Apotex Corp | tolvaptan | 60505-4318 |
Apotex Corp | tolvaptan | 60505-4704 |
Ascend Laboratories LLC | tolvaptan | 67877-636 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
tolvaptan drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 |
>Company | >Ingredient | >NDC |
tolvaptan drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | tolvaptan | 49884-768 |
Otsuka America Pharmaceutical Inc | tolvaptan | 59148-020 |
Apotex Corp | tolvaptan | 60505-4317 |
Apotex Corp | tolvaptan | 60505-4318 |
Apotex Corp | tolvaptan | 60505-4704 |
Ascend Laboratories LLC | tolvaptan | 67877-636 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
tolvaptan drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Apotex Corp | tolvaptan | 60505-4317 |
Apotex Corp | tolvaptan | 60505-4318 |
>Company | >Ingredient | >NDC |
tolvaptan drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 |
Par Pharmaceutical Inc | tolvaptan | 49884-768 |
Otsuka America Pharmaceutical Inc | tolvaptan | 59148-020 |
Apotex Corp | tolvaptan | 60505-4704 |
Ascend Laboratories LLC | tolvaptan | 67877-636 |
Novadoz Pharmaceuticals LLC | tolvaptan | 72205-130 |
>Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
tolvaptan drug variants containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | tolvaptan | 31722-869 |
Par Pharmaceutical Inc | tolvaptan | 49884-768 |
Otsuka America Pharmaceutical Inc | tolvaptan | 59148-020 |
Apotex Corp | tolvaptan | 60505-4704 |
Ascend Laboratories LLC | tolvaptan | 67877-636 |
Novadoz Pharmaceuticals LLC | tolvaptan | 72205-130 |
>Company | >Ingredient | >NDC |
tolvaptan drug variants not containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Apotex Corp | tolvaptan | 60505-4317 |
Apotex Corp | tolvaptan | 60505-4318 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.